Litcius/Paper detail

Penidihydrocitrinins A–C: New Polyketides from the Deep-Sea-Derived Penicillium citrinum W17 and Their Anti-Inflammatory and Anti-Osteoporotic Bioactivities

Yong Zhang, Chun-Lan Xie, Yuan Wang, Xiwen He, Ming‐Min Xie, Youyong Li, Kai Zhang, Zheng‐Biao Zou, Longhe Yang, Ren Xu, Xian‐Wen Yang

2023Marine Drugs14 citationsDOIOpen Access PDF

Abstract

Three new polyketides (penidihydrocitrinins A–C, 1–3) and fourteen known compounds (4–17) were isolated from the deep-sea-derived Penicillium citrinum W17. Their structures were elucidated by comprehensive analyses of 1D and 2D NMR, HRESIMS, and ECD calculations. Compounds 1–17 were evaluated for their anti-inflammatory and anti-osteoporotic bioactivities. All isolates exhibited significant inhibitory effects on LPS-stimulated nitric oxide production in murine brain microglial BV-2 cells in a dose-response manner. Notably, compound 14 displayed the strongest effect with the IC50 value of 4.7 µM. Additionally, compounds 6, 7, and 8 significantly enhanced osteoblast mineralization, which was comparable to that of the positive control, purmorphamine. Furthermore, these three compounds also suppressed osteoclastogenesis in a dose-dependent manner under the concentrations of 2.5 μM, 5.0 μM, and 10 μM.

Topics & Concepts

Penicillium citrinumIC50ChemistryStereochemistryNitric oxideTwo-dimensional nuclear magnetic resonance spectroscopyPenicilliumPositive controlBiochemistryIn vitroTraditional medicineMedicineFood scienceOrganic chemistryMicrobial Natural Products and BiosynthesisMarine Sponges and Natural ProductsAlkaloids: synthesis and pharmacology